GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ono Pharmaceutical Co Ltd (OTCPK:OPHLY) » Definitions » Cyclically Adjusted PB Ratio

Ono Pharmaceutical Co (Ono Pharmaceutical Co) Cyclically Adjusted PB Ratio : 1.76 (As of May. 16, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Ono Pharmaceutical Co Cyclically Adjusted PB Ratio?

As of today (2024-05-16), Ono Pharmaceutical Co's current share price is $4.79. Ono Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $2.72. Ono Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is 1.76.

The historical rank and industry rank for Ono Pharmaceutical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

OPHLY' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.83   Med: 2.8   Max: 3.91
Current: 1.89

During the past years, Ono Pharmaceutical Co's highest Cyclically Adjusted PB Ratio was 3.91. The lowest was 1.83. And the median was 2.80.

OPHLY's Cyclically Adjusted PB Ratio is ranked worse than
50.15% of 670 companies
in the Drug Manufacturers industry
Industry Median: 1.885 vs OPHLY: 1.89

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Ono Pharmaceutical Co's adjusted book value per share data for the three months ended in Mar. 2024 was $3.756. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.72 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Ono Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Ono Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ono Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Ono Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.70 3.00 2.98 2.46 2.00

Ono Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.46 2.27 2.44 2.09 2.00

Competitive Comparison of Ono Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ono Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Ono Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Ono Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Ono Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=4.79/2.72
=1.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ono Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Ono Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3.756/107.2000*107.2000
=3.756

Current CPI (Mar. 2024) = 107.2000.

Ono Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 2.750 98.000 3.008
201409 2.645 98.500 2.879
201412 2.421 97.900 2.651
201503 2.458 97.900 2.691
201506 2.406 98.400 2.621
201509 2.435 98.500 2.650
201512 2.474 98.100 2.703
201603 2.625 97.900 2.874
201606 2.823 98.100 3.085
201609 3.000 98.000 3.282
201612 2.734 98.400 2.979
201703 2.891 98.100 3.159
201706 2.914 98.500 3.171
201709 2.938 98.800 3.188
201712 2.999 99.400 3.234
201803 3.206 99.200 3.465
201806 3.190 99.200 3.447
201809 3.266 99.900 3.505
201812 3.143 99.700 3.379
201903 3.251 99.700 3.496
201906 3.328 99.800 3.575
201909 3.412 100.100 3.654
201912 3.581 100.500 3.820
202003 3.489 100.300 3.729
202006 3.621 99.900 3.886
202009 3.826 99.900 4.106
202012 4.006 99.300 4.325
202103 3.896 99.900 4.181
202106 3.909 99.500 4.212
202109 4.086 100.100 4.376
202112 3.920 100.100 4.198
202203 3.776 101.100 4.004
202206 3.423 101.800 3.605
202209 3.356 103.100 3.489
202212 3.650 104.100 3.759
202303 3.788 104.400 3.890
202306 3.682 105.200 3.752
202309 3.646 106.200 3.680
202312 3.825 106.800 3.839
202403 3.756 107.200 3.756

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ono Pharmaceutical Co  (OTCPK:OPHLY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Ono Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Ono Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ono Pharmaceutical Co (Ono Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, JPN, 541-8564
Ono Pharmaceutical is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. It maintains a global business in specialty pharmaceuticals. The company breaks out its revenue of goods and products into eight segments. The vast majority of Ono's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of Ono's sales are generated in Japan, followed by the rest of Asia and Europe.

Ono Pharmaceutical Co (Ono Pharmaceutical Co) Headlines